These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11266906)

  • 1. Downregulation of nuclear factor kappa B expression in primate cardiac allograft arteries after E2F decoy transfection.
    Kawauchi M; Suzuki J; Wada Y; Morishita R; Kaneda Y; Isobe M; Amano J; Takamoto S
    Transplant Proc; 2001; 33(1-2):451. PubMed ID: 11266906
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates.
    Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M
    Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
    Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ
    Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor kappa B expression in primate cardiac allograft arteries.
    Suzuki J; Kawauchi M; Wada Y; Isobe M; Takamoto S; Amano J
    Transplant Proc; 2001; 33(1-2):606. PubMed ID: 11266980
    [No Abstract]   [Full Text] [Related]  

  • 5. Caspase-dependent apoptosis by ectopic expression of E2F-4.
    Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
    Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
    Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.
    Maeshima Y; Kashihara N; Yasuda T; Sugiyama H; Sekikawa T; Okamoto K; Kanao K; Watanabe Y; Kanwar YS; Makino H
    J Clin Invest; 1998 Jun; 101(11):2589-97. PubMed ID: 9616230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogenic properties of the DP family of proteins.
    Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
    Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ
    Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques.
    Bennett MR; Macdonald K; Chan SW; Boyle JJ; Weissberg PL
    Circ Res; 1998 Apr; 82(6):704-12. PubMed ID: 9546379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
    Inman GJ; Farrell PJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.
    Liu N; Lucibello FC; Körner K; Wolfraim LA; Zwicker J; Müller R
    Nucleic Acids Res; 1997 Dec; 25(24):4915-20. PubMed ID: 9396796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
    Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
    Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of E2F: a family of transcription factors involved in proliferation control.
    Black AR; Azizkhan-Clifford J
    Gene; 1999 Sep; 237(2):281-302. PubMed ID: 10521653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor E2F controls the reversible gamma delta T cell growth arrest mediated through WC1.
    Kirkham PA; Lam EW; Takamatsu HH; Parkhouse RM
    J Immunol; 1998 Aug; 161(4):1630-6. PubMed ID: 9712024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F: a nodal point in cell cycle regulation.
    Bernards R
    Biochim Biophys Acta; 1997 Dec; 1333(3):M33-40. PubMed ID: 9426200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.